Very bullish moves in the past few days, maybe the POT stocks have finally found a bottom and the negative vaping news flow has decreased .
Source Yahoo.
MedMen Enterprises (MMNFF – Get Report) recently announced it opened three new retail outlets in Florida, bringing the total number of operating stores in the U.S. to 29.
At this time, MedMen has four retail stores in Florida opened, and has licenses to open another 31, bringing the total ceiling in the state to 35. Before the end of 2019 it has plans to open another eight in the Florida market.
The three newest stores are located in Key West, Pensacola, and St. Petersburg.
In this article we'll look at why investors will need to be patient wit MedMen and why it'll take time before it generates a profit.
MedMen Stock Could More Than Triple
The word on the Street rings largely bullish on this cannabis stock, with TipRanks analytics demonstrating MedMen as a Buy. Out of 7 analysts polled by TipRanks in the last 7 months, 6 are bullish on MedMen shares, while only one is bearish. With a return potential of nearly 290%, the stock's consensus target price stands at $5.40.
Source Yahoo.
MedMen Enterprises (MMNFF – Get Report) recently announced it opened three new retail outlets in Florida, bringing the total number of operating stores in the U.S. to 29.
At this time, MedMen has four retail stores in Florida opened, and has licenses to open another 31, bringing the total ceiling in the state to 35. Before the end of 2019 it has plans to open another eight in the Florida market.
The three newest stores are located in Key West, Pensacola, and St. Petersburg.
In this article we'll look at why investors will need to be patient wit MedMen and why it'll take time before it generates a profit.
MedMen Stock Could More Than Triple
The word on the Street rings largely bullish on this cannabis stock, with TipRanks analytics demonstrating MedMen as a Buy. Out of 7 analysts polled by TipRanks in the last 7 months, 6 are bullish on MedMen shares, while only one is bearish. With a return potential of nearly 290%, the stock's consensus target price stands at $5.40.